A Phase II Study of the Peroxisome Proliferator-Activated Receptor Gamma
Agonist; Efatutazone in Patients with Previously Treated; Unresectable Myxoid Liposarcoma
Agonist; Efatutazone in Patients with Previously Treated; Unresectable Myxoid Liposarcoma